OpenAI’s latest image update to ChatGPT isn’t just a boon for Studio Ghibli fans. It’s also a gift to businesses of all sizes ...

As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...

Isomorphic Labs, which broke off from Google's DeepMind in 2021, raised $600 million from investors in a new funding round ...

Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into ...

The companies Isomorphic Labs, DBV Technologies, and Genfit bagged the biggest biotech funding rounds overall in March 2025.

UK-based AI-first development company Isomorphic Labs revealed that it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

Though Isomorphic is burning through millions in R&D costs now, investors have high hopes for the potential of AI drug ...

Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...

The latest health updates include the FDA's approval of a new freeze-dried mpox vaccine, and a judge's dismissal of a $10 ...

AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...